Literature DB >> 28634280

Surgical clipping or endovascular coiling for unruptured intracranial aneurysms: a pragmatic randomised trial.

Tim E Darsaut1, J Max Findlay1, Elsa Magro2, Marc Kotowski3, Daniel Roy3, Alain Weill3, Michel W Bojanowski4, Chiraz Chaalala4, Daniela Iancu5, Howard Lesiuk6, John Sinclair6, Felix Scholtes7, Didier Martin7, Michael M Chow1, Cian J O'Kelly1, John H Wong8, Ken Butcher9, Allan J Fox10, Adam S Arthur11, Francois Guilbert3, Lu Tian12, Miguel Chagnon13, Suzanne Nolet14, Guylaine Gevry14, Jean Raymond3.   

Abstract

BACKGROUND: Unruptured intracranial aneurysms (UIAs) are increasingly diagnosed and are commonly treated using endovascular treatment or microsurgical clipping. The safety and efficacy of treatments have not been compared in a randomised trial. How to treat patients with UIAs suitable for both options remains unknown.
METHODS: We randomly allocated clipping or coiling to patients with one or more 3-25 mm UIAs judged treatable both ways. The primary outcome was treatment failure, defined as: initial failure of aneurysm treatment, intracranial haemorrhage or residual aneurysm on 1-year imaging. Secondary outcomes included neurological deficits following treatment, hospitalisation >5 days, overall morbidity and mortality and angiographic results at 1 year.
RESULTS: The trial was designed to include 260 patients. An analysis was performed for slow accrual: 136 patients were enrolled from 2010 through 2016 and 134 patients were treated. The 1-year primary outcome, available for 104 patients, was reached in 5/48 (10.4% (4.5%-22.2%)) patients allocated surgical clipping, and 10/56 (17.9% (10.0%-29.8%)) patients allocated endovascular coiling (OR: 0.54 (0.13-1.90), p=0.40). Morbidity and mortality (modified Rankin Scale>2) at 1 year occurred in 2/48 (4.2% (1.2%-14.0%)) and 2/56 (3.6% (1.0%-12.1%)) patients allocated clipping and coiling, respectively. New neurological deficits (15/65 vs 6/69; OR: 3.12 (1.05-10.57), p=0.031), and hospitalisations beyond 5 days (30/65 vs 6/69; OR: 8.85 (3.22-28.59), p=0.0001) were more frequent after clipping.
CONCLUSION: Surgical clipping or endovascular coiling of UIAs did not show differences in morbidity at 1 year. Trial continuation and additional randomised evidence will be necessary to establish the supposed superior efficacy of clipping. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  endovascular coiling; pragmatic trial; randomized controlled trial; surgical clipping; unruptured intracranial aneurysm

Mesh:

Year:  2017        PMID: 28634280     DOI: 10.1136/jnnp-2016-315433

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Unruptured Intracranial Aneurysms- Pathogenesis and Individualized Management.

Authors:  Nima Etminan; Arnd Dörfler; Helmuth Steinmetz
Journal:  Dtsch Arztebl Int       Date:  2020-04-03       Impact factor: 5.594

2.  Clipping treatment of posterior communicating artery aneurysms associated with arteriosclerosis and calcification: A single center study of 136 cases.

Authors:  Lei Shi; Jing Yu; Ying Zhao; Kan Xu; Jinlu Yu
Journal:  Exp Ther Med       Date:  2017-11-17       Impact factor: 2.447

3.  Predictors of Cerebral Aneurysm Rupture after Coil Embolization: Single-Center Experience with Recanalized Aneurysms.

Authors:  Y Funakoshi; H Imamura; S Tani; H Adachi; R Fukumitsu; T Sunohara; Y Omura; Y Matsui; N Sasaki; T Fukuda; R Akiyama; K Horiuchi; S Kajiura; M Shigeyasu; K Iihara; N Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

Review 4.  A meta-analysis on the prevalence of anxiety and depression in patients with unruptured intracranial aneurysms: exposing critical treatment gaps.

Authors:  Katrina Hannah D Ignacio; Juan Silvestre G Pascual; Sedric John V Factor; Kathleen Joy O Khu
Journal:  Neurosurg Rev       Date:  2022-03-15       Impact factor: 3.042

5.  Angiographic results of surgical or endovascular treatment of intracranial aneurysms: a systematic review and inter-observer reliability study.

Authors:  Anass Benomar; Behzad Farzin; David Volders; Guylaine Gevry; Justine Zehr; Robert Fahed; William Boisseau; Jean-Christophe Gentric; Elsa Magro; Lorena Nico; Daniel Roy; Alain Weill; Charbel Mounayer; François Guilbert; Laurent Létourneau-Guillon; Gregory Jacquin; Chiraz Chaalala; Marc Kotowski; Thanh N Nguyen; David Kallmes; Phil White; Tim E Darsaut; Jean Raymond
Journal:  Neuroradiology       Date:  2021-02-24       Impact factor: 2.804

Review 6.  Management of unruptured incidentally found intracranial saccular aneurysms.

Authors:  Vikram A Mehta; Charis A Spears; Jihad Abdelgadir; Timothy Y Wang; Eric W Sankey; Andrew Griffin; C Rory Goodwin; Ali Zomorodi
Journal:  Neurosurg Rev       Date:  2020-10-06       Impact factor: 3.042

Review 7.  Aneurysmal Subarachnoid Hemorrhage.

Authors:  David Y Chung; Mohamad Abdalkader; Thanh N Nguyen
Journal:  Neurol Clin       Date:  2021-03-31       Impact factor: 3.806

8.  Treatments for unruptured intracranial aneurysms.

Authors:  Felipe Gomes de Barros Pontes; Edina Mk da Silva; Jose Cc Baptista-Silva; Vladimir Vasconcelos
Journal:  Cochrane Database Syst Rev       Date:  2021-05-10

9.  LncRNA SAMMSON Overexpression Suppresses Vascular Smooth Muscle Cell Proliferation via Inhibiting miR-130a Maturation to Participate in Intracranial Aneurysm.

Authors:  Wen Pan; Yuan Gao; Weifeng Wan; Wenfeng Xiao; Chao You
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-04       Impact factor: 2.570

10.  Readmission Trends Related to Unruptured Intracranial Aneurysm Treatment.

Authors:  Tapan Mehta; Ninad Desai; Smit Patel; Shailesh Male; Adam Khan; Andrew Walker Grande; Ramachandra Prasad Tummala; Bharathi Dasan Jagadeesan
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.